EE16 Budget Impact Analysis of the Introduction of Dexcom ONE for the Treatment of Patients With T2 Diabetes on an Intensive Insulin Schedule From the Perspective of the Italian Healthcare Payer
| Autor: | Genugten, M., Grifi, M. |
|---|---|
| Zdroj: | In Value in Health December 2023 26(12) Supplement:S53-S53 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect